Annovis Bio, Inc. (ANVS) Financials

ANVS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 10.2 million 3.6 million
2023-06-30 22.8 million 2.1 million
2023-03-31 25.5 million 5.4 million
2022-12-31 36.0 million 7.7 million

ANVS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.4 million 632191
2023-06-30 -9.6 million 1.6 million
2023-03-31 -11.6 million 1.5 million
2022-12-31 -3.6 million 1.5 million

ANVS Net Income

No data available :(

ANVS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 6.4 million - -
2023-06-30 15.7 million - -
2023-03-31 16.8 million - -
2022-12-31 28.4 million - -

ANVS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 9.0 million
2023-06-30 9.0 million
2023-03-31 8.2 million
2022-12-31 8.2 million

ANVS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 13.8 million 1.0 million -
2023-06-30 - 8.3 million 1.5 million -
2023-03-31 - 7.8 million 2.2 million -
2022-12-31 - 1.6 million 1.6 million -

ANVS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 13.8 million
2023-06-30 - 8.3 million
2023-03-31 - 7.8 million
2022-12-31 - 1.6 million

ANVS

Price: $18.01

52 week price:
5.42
22.49

Earnings Per Share: -6.23 USD

P/E Ratio: -2.06

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 103127

Market Capitalization: 128.1 million

Links: